Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Expression of concern: HDACI regulates the PI3K/Akt signaling pathway to reverse MCF-7/PTX resistance by inhibiting SET
Weipeng Zhangab,
Xiaowei Zhenga,
Ti Menga,
Haisheng Youa,
Yalin Donga,
Jianfeng Xing*c and
Siying Chen*a
aDepartment of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277 of Yanta West Road, Xi'an, Shaanxi 710061, PR China. E-mail: ychen0326@163.com; Fax: +86-29-85323240; Tel: +86-29-85323243
bDepartment of Pharmacy, The Eighth Hospital of Xi'an, Xi'an, Shaanxi 710061, PR China
cSchool of Pharmacy, Xi'an Jiaotong University, No. 76 of Yanta West Road, Xi'an, Shaanxi 710061, PR China. E-mail: xajdxjf@mail.xjtu.edu.cn; Fax: +86-29-82655130; Tel: +86-29-82655130
First published on 4th September 2024
Abstract
Expression of concern for ‘HDACI regulates the PI3K/Akt signaling pathway to reverse MCF-7/PTX resistance by inhibiting SET’ by Weipeng Zhang et al., RSC Adv., 2016, 6, 48072–48082, https://doi.org/10.1039/C6RA06423J
RSC Advances is publishing this expression of concern in order to alert readers that concerns have been raised regarding the western blot images in Fig. 2a and b, 4a and b, 5c, and 6a and b. The authors have been asked to provide the raw data for these concerns but have not been able to do this. An expression of concern will continue to be associated with the article until we receive conclusive evidence regarding the reliability of the reported data.
Laura Fisher
23rd August 2024
Executive Editor, RSC Advances
| This journal is © The Royal Society of Chemistry 2024 |